Literature DB >> 24344652

Optogenetics' promise: pacing and cardioversion by light?

Christina M Ambrosi1, Emilia Entcheva.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24344652      PMCID： PMC4035099          DOI： 10.2217/fca.13.89

Source DB:  PubMed          Journal:  Future Cardiol        ISSN： 1479-6678


× No keyword cloud information.
  21 in total

Review 1.  Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.

Authors:  Sangeetha Hareendran; Balaji Balakrishnan; Dwaipayan Sen; Sanjay Kumar; Alok Srivastava; Giridhara R Jayandharan
Journal:  Rev Med Virol       Date:  2013-09-10       Impact factor: 6.989

Review 2.  Next-generation optical technologies for illuminating genetically targeted brain circuits.

Authors:  Karl Deisseroth; Guoping Feng; Ania K Majewska; Gero Miesenböck; Alice Ting; Mark J Schnitzer
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

3.  Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study.

Authors:  Robert G Hauser; David L Hayes; Linda M Kallinen; David S Cannom; Andrew E Epstein; Adrian K Almquist; Susan L Song; G Frank O Tyers; Stephen C Vlay; Marleen Irwin
Journal:  Heart Rhythm       Date:  2006-10-12       Impact factor: 6.343

4.  Optogenetics in neural systems.

Authors:  Ofer Yizhar; Lief E Fenno; Thomas J Davidson; Murtaza Mogri; Karl Deisseroth
Journal:  Neuron       Date:  2011-07-14       Impact factor: 17.173

5.  Psychophysiologic and affective parameters associated with pain intensity of cardiac cardioverter defibrillator shock discharges.

Authors:  Jens Baumert; Claus Schmitt; Karl-Heinz Ladwig
Journal:  Psychosom Med       Date:  2006 Jul-Aug       Impact factor: 4.312

Review 6.  Cardiac optogenetics.

Authors:  Emilia Entcheva
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-01       Impact factor: 4.733

7.  Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.

Authors:  Raj R Makkar; Rachel R Smith; Ke Cheng; Konstantinos Malliaras; Louise Ej Thomson; Daniel Berman; Lawrence Sc Czer; Linda Marbán; Adam Mendizabal; Peter V Johnston; Stuart D Russell; Karl H Schuleri; Albert C Lardo; Gary Gerstenblith; Eduardo Marbán
Journal:  Lancet       Date:  2012-02-14       Impact factor: 79.321

8.  ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation.

Authors:  John Y Lin; Per Magne Knutsen; Arnaud Muller; David Kleinfeld; Roger Y Tsien
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

9.  Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model.

Authors:  John C Williams; Jianjin Xu; Zhongju Lu; Aleksandra Klimas; Xuxin Chen; Christina M Ambrosi; Ira S Cohen; Emilia Entcheva
Journal:  PLoS Comput Biol       Date:  2013-09-12       Impact factor: 4.475

10.  A comprehensive multiscale framework for simulating optogenetics in the heart.

Authors:  Patrick M Boyle; John C Williams; Christina M Ambrosi; Emilia Entcheva; Natalia A Trayanova
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more
  14 in total

1.  Optogenetic versus Electrical Stimulation of Human Cardiomyocytes: Modeling Insights.

Authors:  John C Williams; Emilia Entcheva
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

2.  Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach.

Authors:  Thomas V Karathanos; Patrick M Boyle; Natalia A Trayanova
Journal:  Europace       Date:  2014-11       Impact factor: 5.214

3.  Fiat lux in understanding cardiac pacing, resynchronization and signalling by way of optogenetics.

Authors:  Emilia Entcheva
Journal:  Cardiovasc Res       Date:  2014-04-22       Impact factor: 10.787

Review 4.  Cardiac optogenetics: a decade of enlightenment.

Authors:  Emilia Entcheva; Matthew W Kay
Journal:  Nat Rev Cardiol       Date:  2020-12-18       Impact factor: 32.419

Review 5.  Cardiac applications of optogenetics.

Authors:  Christina M Ambrosi; Aleksandra Klimas; Jinzhu Yu; Emilia Entcheva
Journal:  Prog Biophys Mol Biol       Date:  2014-07-15       Impact factor: 3.667

6.  Inhibitory luminopsins: genetically-encoded bioluminescent opsins for versatile, scalable, and hardware-independent optogenetic inhibition.

Authors:  Jack K Tung; Claire-Anne Gutekunst; Robert E Gross
Journal:  Sci Rep       Date:  2015-09-24       Impact factor: 4.379

7.  Channelrhodopsin2 current during the action potential: "optical AP clamp" and approximation.

Authors:  Emilia Entcheva; John C Williams
Journal:  Sci Rep       Date:  2014-07-25       Impact factor: 4.379

8.  Non-invasive red-light optogenetic control of Drosophila cardiac function.

Authors:  Jing Men; Airong Li; Jason Jerwick; Zilong Li; Rudolph E Tanzi; Chao Zhou
Journal:  Commun Biol       Date:  2020-06-29

9.  Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.

Authors:  Patrick M Boyle; Michael J Murphy; Thomas V Karathanos; Sohail Zahid; Robert C Blake; Natalia A Trayanova
Journal:  J Physiol       Date:  2017-12-28       Impact factor: 5.182

10.  Anion channelrhodopsins for inhibitory cardiac optogenetics.

Authors:  Elena G Govorunova; Shane R Cunha; Oleg A Sineshchekov; John L Spudich
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.